Health
US health department eases enforcement on six unproven peptides
The organization that warned wider peptide access could increase harm and weaken incentives for clinical trials.
Center for Science in the Public Interest is a consumer advocacy group.
The organization that warned wider peptide access could increase harm and weaken incentives for clinical trials.
The science-based advocacy group urged the FDA to reject its advisory panel’s peptide recommendations.
5 min